Evidence map›Paper›PMID 26777690›Full record

ArticleCell metabolism2016

Ligand Activation of ERRα by Cholesterol Mediates Statin and Bisphosphonate Effects.

Wei Wei, Adam G Schwaid, Xueqian Wang, Xunde Wang, Shili Chen, Qian Chu, Alan Saghatelian, Yihong Wan

Open access · bronzeAbstract read
In one paragraph

Article in Cell metabolism, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed, 1 pooled it
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 1 synthesis or guideline pooled it, 161 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Wei WeiDepartment of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Adam G SchwaidDepartment of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA.
Xueqian WangDepartment of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Xunde WangDepartment of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Shili ChenClayton Foundation Laboratories of Peptide Biology and Helmsley Center for Genomic Medicine, Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
Qian ChuClayton Foundation Laboratories of Peptide Biology and Helmsley Center for Genomic Medicine, Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
Alan SaghatelianDepartment of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA; Clayton Foundation Laboratories of Peptide Biology and Helmsley Center for Genomic Medicine, Salk Institute for Biological Studies, La Jolla, CA 92037, USA. Electronic address: asaghatelian@salk.edu.
Yihong WanDepartment of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. Electronic address: yihong.wan@utsouthwestern.edu.
Salk Institute for Biological Studies · USThe University of Texas Southwestern Medical Center · USHarvard University · USSouthwestern Medical Center · US

Funding

Viral Vector Core (VVC)P30CA014195 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI Ye Zheng · 1985 to 2026
$82.8M
Discovery metabolite profiling of the prolyl peptidasesDP2OD002374 · OD · HARVARD UNIVERSITY · PI SAGHATELIAN, ALAN · 2007 to 2009
$2.6M
Connection of Mineral and Energy Metabolism by the Nuclear Receptor PPAR-gammaR01DK089113 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI WAN, YIHONG · 2011 to 2015
$1.8M
NCI NIH HHS P30 CA014195NIDDK NIH HHS R01 DK089113NIDDK NIH HHS R01DK089113NIH HHS DP2 OD002374
6 · The paper itself

Abstract

Nuclear receptors (NRs) are key regulators of gene expression and physiology. Nearly half of all human NRs lack endogenous ligands including estrogen-related receptor α (ERRα). ERRα has important roles in cancer, metabolism, and skeletal homeostasis. Affinity chromatography of tissue lipidomes with the ERRα ligand-binding domain (LBD) and subsequent transcriptional assays identified cholesterol as an endogenous ERRα agonist. Perturbation of cholesterol biosynthesis or inhibition of ERRα revealed the interdependence of cholesterol and ERRα. In bone, the effects of cholesterol, statin, and bisphosphonate on osteoclastogenesis require ERRα; and consequently, cholesterol-induced bone loss or bisphosphonate osteoprotection is lost in ERRα knockout mice. Furthermore, statin induction of muscle toxicity and cholesterol suppression of macrophage cytokine secretion are impaired by loss or inhibition of ERRα. These findings reveal a key step in ERRα regulation and explain the actions of two highly prescribed drugs, statins and bisphosphonates.

Indexed as

AnimalsBinding SitesBone ResorptionCell DifferentiationCell LineCholesterolDiphosphonatesERRalpha Estrogen-Related ReceptorFemaleHydroxymethylglutaryl-CoA Reductase InhibitorsLigandsMacrophagesMaleMice, Inbred C57BLMuscle, SkeletalOsteoclastsCholesterolDiphosphonatesERRalpha Estrogen-Related ReceptorHydroxymethylglutaryl-CoA Reductase InhibitorsLigandsReceptors, EstrogenSimvastatin

Identifiers

PMID26777690
PMCPMC4785078
OpenAlexW2235799934

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.